Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
12.68
-0.06 (-0.47%)
Aug 8, 2025, 2:47 PM - Market open

Despegar.com Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1,2271,013----
Upgrade
Enterprise Value
1,168985----
Upgrade
Last Close Price
12.7410.51----
Upgrade
Forward PE
29.66200.19----
Upgrade
PS Ratio
5.565.99----
Upgrade
PB Ratio
13.5913.71----
Upgrade
P/TBV Ratio
16.4017.76----
Upgrade
EV/Sales Ratio
5.285.83----
Upgrade
Debt / Equity Ratio
0.420.530.41-6.201.850.80
Upgrade
Debt / EBITDA Ratio
5.60-----
Upgrade
Debt / FCF Ratio
7.22-----
Upgrade
Asset Turnover
1.281.030.19--0.10
Upgrade
Inventory Turnover
1.251.00----
Upgrade
Quick Ratio
2.142.213.181.778.9917.30
Upgrade
Current Ratio
2.792.753.641.819.1717.44
Upgrade
Return on Equity (ROE)
-3.63%-60.44%-481.35%-481.49%-64.30%10.56%
Upgrade
Return on Assets (ROA)
0.82%-16.11%-57.92%-31.32%-19.14%-9.90%
Upgrade
Return on Capital (ROIC)
1.19%-22.41%-73.72%-35.73%-20.73%-11.64%
Upgrade
Return on Capital Employed (ROCE)
1.70%-----
Upgrade
Earnings Yield
-0.24%-4.82%----
Upgrade
FCF Yield
0.43%-4.63%----
Upgrade
Buyback Yield / Dilution
-5.10%-18.67%-33.41%-2.66%-6.54%-46.89%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q